ONontonexa
Menu
Classify ProductsHS Code LookupValidate CodePlansResourcesProduct GuidesHTS CodesCanada TariffEU TariffUK TariffIndia HS
HTS code reference›Chapter 30: Pharmaceutical products›3002.41.00.00
US HTS · 2026 REVISION 12

HTS Code 3002.41.00.00

Vaccines for human medicine

Official tariff path

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified: › Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: › Vaccines for human medicine

Level: statistical10General duty: FreeUnit: kg
WHAT THIS PAGE ADDSRead the code in context

Official wording plus the product examples, decision checks and next steps that a raw tariff lookup does not provide.

RELATED PRODUCTDescribe your product

Find a matching product →

NEXT STEPVerify your shipment

Compare this code with your exact product →

Does HTS 3002.41.00.00 fit your product?

This is the fastest way to use the page: compare the exact commercial description with the legal wording, then check the closest child or sibling provision. A valid code is not automatically the right code for every product in the same category.

  • The product must match the tariff wording: Vaccines for human medicine.
  • This page is a reporting provision; verify the complete product description and chapter notes before filing.
  • The displayed duty is Free; origin programs, trade remedies, quotas and taxes may change the final amount.

What does HTS 3002.41.00.00 cover?

This provision appears in the 2026 Harmonized Tariff Schedule of the United States under the following legal tariff hierarchy.

  1. 1Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified:
  2. 2Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products:
  3. 3Vaccines for human medicine

Nearby tariff provisions

These are the alternatives worth comparing when one product fact changes.

3002.12.00Antisera and other blood fractions3002.13.00Immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale3002.14.00Immunological products, mixed, not put up in measured doses or in forms or packings for retail sale3002.15.00Immunological products, put up in measured doses or in forms or packings for retail sale3002.42.00.00Vaccines for veterinary medicine3002.49.00Other3002.51.00.00Cell therapy products3002.59.00.00Other
Official source and limitations

Based on USITC HTS 2026 Revision 12, published July 21, 2026. The general rate does not include every origin-specific program, Section 301 or 232 measure, antidumping or countervailing duty, quota, or other agency requirement.

Open this code in the official USITC search ↗

Read how Ontonexa ranks candidates → · View tariff release notes →